Clinical Trials Browser

Phase NA × INDUSTRY × eribulin × Clear all

NCT01142661 2013-09-20

Compassionate Use of Eribulin for the Treatment of Advanced Breast Cancer Refractory to All Other Marketed Therapies

Phase NA Completed

9 enrolled 8 charts

Breast Neoplasms